BI Bags Third Place For Humira Biosimilar in US With AbbVie Pact

 
• By Dave Wallace and Kevin Grogan
  
Balloons
Cyltezo will be the third Humira biosimilar to launch in 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Business